ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF12.251

F12.251

Billable

Cannabis dependence with psychotic disorder with hallucinations

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F12.251 is a billable code used to indicate a diagnosis of cannabis dependence with psychotic disorder with hallucinations.

Key Diagnostic Point:

Cannabis dependence with psychotic disorder with hallucinations is characterized by a pattern of cannabis use that leads to clinically significant impairment or distress, accompanied by the presence of psychotic symptoms such as hallucinations. This condition arises when an individual develops a tolerance to cannabis, experiences withdrawal symptoms upon cessation, and exhibits compulsive use despite negative consequences. The psychotic disorder component indicates that the individual experiences hallucinations, which can be auditory, visual, or tactile, and are often distressing. These symptoms can significantly impair social, occupational, and personal functioning. The diagnosis requires a thorough clinical assessment, including a detailed history of substance use, mental health evaluation, and consideration of other potential causes of psychosis. Treatment typically involves a combination of psychotherapy, psychoeducation, and, in some cases, pharmacotherapy to manage psychotic symptoms. Early intervention is crucial to prevent further deterioration of mental health and to support recovery.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Differentiating between substance-induced psychosis and primary psychotic disorders.
  • Need for comprehensive documentation of substance use history.
  • Assessment of withdrawal symptoms and their impact on mental health.
  • Potential overlap with other mental health diagnoses.

Audit Risk Factors

  • Inadequate documentation of psychotic symptoms.
  • Failure to differentiate between substance-induced and primary psychotic disorders.
  • Lack of evidence for the severity of dependence.
  • Insufficient detail on treatment plans and patient progress.

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed mental health evaluations, including history of substance use and current symptoms.

Common Clinical Scenarios

Patients presenting with acute psychosis following cannabis use, or chronic users developing persistent psychotic symptoms.

Billing Considerations

Consideration of co-occurring mental health disorders and the need for a multidisciplinary approach to treatment.

Addiction Medicine

Documentation Requirements

Comprehensive substance use history, including frequency, quantity, and context of cannabis use.

Common Clinical Scenarios

Patients in withdrawal experiencing psychotic symptoms, or those in recovery with a history of cannabis dependence.

Billing Considerations

Integration of addiction treatment strategies with mental health interventions.

Coding Guidelines

Inclusion Criteria

Use F12.251 When
  • According to ICD
  • 10 guidelines, F12
  • 251 should be used when there is clear evidence of cannabis dependence accompanied by psychotic symptoms, specifically hallucinations
  • Documentation must support the diagnosis, including the duration and severity of symptoms

Exclusion Criteria

Do NOT use F12.251 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

90834CPT Code

Psychotherapy, 45 minutes with patient

Clinical Scenario

Used for ongoing therapy for patients with cannabis dependence and psychosis.

Documentation Requirements

Document the duration of the session and the focus on substance use and psychotic symptoms.

Specialty Considerations

Psychiatrists may need to coordinate care with addiction specialists.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, including the differentiation of psychotic features, which aids in better treatment planning and resource allocation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, including the differentiation of psychotic features, which aids in better treatment planning and resource allocation.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, including the differentiation of psychotic features, which aids in better treatment planning and resource allocation.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between cannabis dependence and cannabis use disorder?

Cannabis dependence refers specifically to the physiological and psychological reliance on cannabis, while cannabis use disorder encompasses a broader range of issues related to cannabis use, including social and functional impairments.